Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PFE compared with JNJ: revenue, margins and what each company keeps, and the suppliers and customers both name
PFE
Pfizer Inc
Change
Mkt cap
Revenue
Revenue
JNJ
Johnson & Johnson
Change
Mkt cap
Revenue
Revenue
vs
Compare
PFE
Pfizer Inc
vs
JNJ
Johnson & Johnson
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
PFE: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PFE
34
MIRM
Mirum Pharmaceuticals
customer
ICUI
ICU Medical
customer
BEAM
Beam Therapeutics
supplier
ADPT
Adaptive Biotechnologies
supplier
30 more · PFE chain
›
Shared
0
No shared counterparties.
Only JNJ
23
MRK
Merck
supplier
PTGX
Protagonist Therapeutics
supplier
GPK
Graphic Packaging
supplier
ZYME
Zymeworks
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
19 more · JNJ chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PFE, solid
JNJ, dashed
PFE
Pfizer Inc
Change
30.50
▲
+1.83%
· post 30.46
Mkt cap
$174.0B
Revenue
$15.0B
Q2 FY26
Revenue
$62.6B
FY25
JNJ
Johnson & Johnson
Change
273.66
▼
−0.56%
· post 273.74
Closed
Oct 30 '26
Mkt cap
$657.7B
Revenue
$25.4B
Q3 FY26
Revenue
$94.2B
FY25
vs
Compare
Closed
Oct 30 '26
PFE
Pfizer Inc
vs
JNJ
Johnson & Johnson
30.50
▲
+1.83%
post 30.46
Price
273.66
▼
−0.56%
post 273.74
$174.0B
Mkt cap
$657.7B
Q2 FY26
$15.0B
Revenue
$25.4B
Q3 FY26
FY25
$62.6B
Revenue
$94.2B
FY25
Change
Change
PFE
30.50
▲
+1.83%
vs
JNJ
273.66
▼
−0.56%
Closed
Oct 30 '26